Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization.
about
Three decades of beta-lactamase inhibitorsStrategic Design of an Effective -Lactamase Inhibitor: LN-1-255, A 6-ALKYLIDENE-2'-SUBSTITUTED PENICILLIN SULFONEDesign, Synthesis, and Crystal Structures of 6-Alkylidene-2′-Substituted Penicillanic Acid Sulfones as Potent Inhibitors of Acinetobacter baumannii OXA-24 CarbapenemaseEffect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibition.Inhibition of OXA-1 beta-lactamase by penems.Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.Penicillin sulfone inhibitors of class D beta-lactamasesIdentification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymesReclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidime.Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry.New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniaeCeftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactam.Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfoneImportance of position 170 in the inhibition of GES-type β-lactamases by clavulanic acid.High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by Avibactam.
P2860
Q24646623-7B8D8E52-D942-4FD7-A8C4-EB82A9A28672Q27652684-CBAC8836-FB62-484D-82E0-16CAB0D73DD0Q27664292-CE6B9B93-9898-4916-8C90-A28882CEB715Q30484874-8F238407-1221-4BC6-916A-48AE6636B551Q31039961-9F5ED78B-8ED2-4697-AE43-2C5042D6902FQ33344365-458449D8-AC87-4874-905B-E155BFF05BB3Q33601560-D2353BDC-1CB1-4D8D-8B05-4CB8571D6F2CQ33768836-CD3AE21B-8A4B-4823-81A8-3F58F7FC7A48Q33883651-5C4D9E11-E336-4858-BCDD-BCD31FBEE1FDQ34058217-5AB3EC51-55C3-458A-B1C5-D688CB781A5FQ34800304-796F1C26-F6E6-4355-8D35-DA0CCBC4ADA8Q37576889-F6A46F80-15DE-4208-ACD7-3B06F66D5020Q39037981-00CF3DC7-EE98-4A29-BB9D-65F6CAAD3A63Q39767332-5AA9D32B-9076-4FD6-9DA5-1F1D005CF0DCQ41327338-2490DEA5-7BCC-469C-AE85-6E0B20E3C4A9Q42111116-B2F63E4F-1C50-4F89-B19A-A9C4BDFC236DQ46628237-8E2D6994-E5B7-42C3-AC87-CCA8F6E73A4CQ50028138-C0E76EA9-4295-4EFC-ADA7-F23922ED523E
P2860
Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inactivation of CMY-2 beta-lac ...... pectroscopic characterization.
@ast
Inactivation of CMY-2 beta-lac ...... pectroscopic characterization.
@en
type
label
Inactivation of CMY-2 beta-lac ...... pectroscopic characterization.
@ast
Inactivation of CMY-2 beta-lac ...... pectroscopic characterization.
@en
prefLabel
Inactivation of CMY-2 beta-lac ...... pectroscopic characterization.
@ast
Inactivation of CMY-2 beta-lac ...... pectroscopic characterization.
@en
P2093
P1476
Inactivation of CMY-2 beta-lac ...... pectroscopic characterization.
@en
P2093
P304
P356
10.1016/S0167-4838(01)00175-3
P407
P577
2001-06-01T00:00:00Z